Patents by Inventor David Munster

David Munster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Binding partners of antibodies specific for dendritic cell antigens
    Patent number: 8895698
    Abstract: The present invention relates to the field of diagnostics, therapeutics and immunological reagents. More particularly, the present invention provides binding partners of antibodies specific for dendritic cell (DC) antigens. The present invention further provides diagnostic and/or therapeutic agent based on the binding partners or antibodies specific for the binding partners.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: November 25, 2014
    Assignee: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventors: Derek Nigel Hart, David Munster, Peter Vukovic
  • BINDING PARTNERS OF ANTIBODIES SPECIFIC FOR DENDRITIC CELL ANTIGENS
    Publication number: 20130085261
    Abstract: The present invention relates to the field of diagnostics, therapeutics and immunological reagents. More particularly, the present invention provides binding partners of antibodies specific for dendritic cell (DC) antigens. The present invention further provides diagnostic and/or therapeutic agent based on the binding partners or antibodies specific for the binding partners.
    Type: Application
    Filed: September 7, 2012
    Publication date: April 4, 2013
    Applicant: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventors: Derek Nigel Hart, David Munster, Peter Vukovic
  • BINDING PARTNERS OF ANTIBODIES SPECIFIC FOR DENDRITIC CELL ANTIGENS
    Publication number: 20100111980
    Abstract: The present invention relates to the field of diagnostics, therapeutics and immunological reagents. More particularly, the present invention provides binding partners of antibodies specific for dendritic cell (DC) antigens. The present invention further provides diagnostic and/or therapeutic agent based on the binding partners or antibodies specific for the binding partners.
    Type: Application
    Filed: December 9, 2005
    Publication date: May 6, 2010
    Applicant: The Corporation of the Trustees of the Order of the Sisters of Mercy in Queensland
    Inventors: Derek Nigel Hart, David Munster, Peter Vukovic
  • Method of immunomodulation
    Publication number: 20060153843
    Abstract: The present invention relates generally to a method for modulating the activity of cells of the immune system, including stimulator and responder cells and to agents useful therefor. More particularly, the present invention relates to a method for preventing or down-regulating one or more functional activities of stimulator and responder cells such as, respectively, antigen-presenting cells and lymphocytes inter alia. The present invention further provides antibodies, which interact specifically with epitopes present on the surface of antigen-presenting cells and lymphocytes, resulting in depletion, down-regulation or destruction of targeted antigen-presenting cells and lymphocytes in vivo or in vitro. The instant invention further provides a method for modulating an immune response in a subject and, in particular, for down-regulating the immuno-activity of an allogeneic immuno-competent graft and/or the immune response of a recipient of a solid organ transplant.
    Type: Application
    Filed: August 15, 2003
    Publication date: July 13, 2006
    Applicant: The Corporation of The Trustees of The Sisters of Mercy in Queensland of South Brisbane
    Inventors: Masato Kato, David Munster, Derek Hart